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1 Glossary of Terms: Vision Screening 
Abnormal test result ƚĞƐƚƌĞƐƵůƚǁŚĞƌĞĂŶŽƌŵĂů “ƉĂƐƐ ?ƌĞƐƉŽŶƐĞĐŽƵůĚŶŽƚďĞ
detected under good conditions. The result on screening 
ĞƋƵŝƉŵĞŶƚŵĂǇŝŶĚŝĐĂƚĞ “ŶŽƌĞƐƉŽŶƐĞ ? ? “ĨĂŝů ? ?Žƌ “ƌĞĨĞƌ ? ?
Attendance rate The proportion of all those invited for screening that are tested 
and receive a result: 
 
x Invited for screening includes all those that are offered 
the screening test. 
x Tested and ƌĞĐĞŝǀĞĂƌĞƐƵůƚĐŽƵůĚďĞĂ “ƉĂƐƐ ?Žƌ “ƌĞĨĞƌƌĂů
ƚŽĚŝĂŐŶŽƐƚŝĐĂƐƐĞƐƐŵĞŶƚ ? ?
 
Attendance rate provides information on the willingness of 
families to participate in screening. 
Compliance with 
referral (percentage) 
The percentage of those who are referred from screening to a 
diagnostic assessment that actually attend the diagnostic 
assessment. 
 
Percentage of compliance provides information on the 
willingness of families to attend the diagnostic assessment after 
referral from screening. 
Coverage The proportion of those eligible for screening that are tested and 
receive a result: 
 
x Eligible for screening includes those within the population 
that are covered under the screening or health care 
programme. 
x dĞƐƚĞĚĂŶĚƌĞĐĞŝǀĞĂƌĞƐƵůƚĐŽƵůĚďĞĂ “ƉĂƐƐ ?Žƌ “ƌĞĨƌƚŽ 
ĚŝĂŐŶŽƐƚŝĐĂƐƐĞƐƐŵĞŶƚ ? ?
 
Factors such as being offered screening, willingness to 
participate, missed screening, ability to complete the screen, and 
ability to document the screening results will influence the 
coverage. 
False negatives The percentage of children with a visual deficit (defined by the 
ƚĂƌŐĞƚĐŽŶĚŝƚŝŽŶ )ƚŚĂƚƌĞĐĞŝǀĞĂƌĞƐƵůƚŽĨ “ƉĂƐƐ ?ĚƵƌŝŶŐƐĐƌĞĞŶŝŶŐ ? 
 
Example: If 100 children with visual deficit are screened, and 1 
child passes the screening, the percentage of false negatives is 
1%. 
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False positives The percentage of children with normal vision that are referred 
from screening to a diagnostic assessment. 
Guidelines Recommendations or instructions provided by an authoritative 
body on the practice of screening in the country or region. 
Vision screening 
professional 
A person qualified to perform vision screening, according to the 
practice in the country or region. 
Inconclusive test 
result 
ƚĞƐƚƌĞƐƵůƚǁŚĞƌĞĂŶŽƌŵĂů “ƉĂƐƐ ?ƌĞƐƉŽŶƐĞĐŽƵůĚŶŽƚďĞ
detected due to poor test conditions or poor cooperation of the 
child.  
Invited for screening Infants/children and their families who are offered screening. 
Outcome of vision 
screening 
An indication of the effectiveness or performance of screening, 
such as a measurement of coverage rate, referral rate, number of 
children detected, etc. 
Untreated amblyopia Those children who have not received treatment for amblyopia 
due to missed screening or missed follow-up appointment. 
Persistent amblyopia Amblyopia that is missed by screening, or present after the child 
has received treatment. 
Positive predictive 
value 
The percentage of children referred from screening who have a 
confirmed vision loss. 
 
For example, if 100 babies are referred from screening for 
diagnostic assessment and 10 have normal vision and 90 have a 
confirmed visual defect, the positive predictive value would be 
90%. 
Prevalence The percentage or number of individuals with a specific disease 
or condition. Prevalence can either be expressed as a percentage 
or as a number out of 1000 individuals within the same 
demographic. 
Programme An organised system for screening, which could be based 
nationally, regionally or locally. 
Protocol Documented procedure or sequence for screening, which could 
include which tests are performed, when tests are performed, 
procedures for passing and referring, and so forth. 
Quality assurance A method for checking and ensuring that screening is functioning 
adequately and meeting set goals and benchmarks. 
Referral criteria A pre-determined cut-off boundary for when a child should be 
re-tested or seen for a diagnostic assessment.  
Risk babies / Babies 
at-risk 
All infants that are considered to be at-risk or have risk-factors 
for vision defects/ophthalmic pathology according to the 
screening programme. 
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Two common risk factors are admission to the neonatal-intensive 
care unit (NICU) or born prematurely. However, other risk factors 
for visual defects may also be indicated in the screening 
programme. 
Sensitivity The percentage of children with visual defects that are identified 
via the screening programme. 
 
For example, if 100 babies with visual defects are tested, and 98 
of these babies are referred for diagnostic assessment and 2 pass 
the screening, the sensitivity is 98%. 
Specificity The percentage of children with normal vision that pass the 
screening. 
 
For example, if 100 babies with normal vision are tested, and 10 
of these babies are referred for diagnostic assessment and 90 
pass the screening, the specificity is 90%. 
Target condition The visual defect you are aiming to detect via the screening 
programme. 
Well, healthy babies Infants who are not admitted into the NICU or born prematurely 
(born after a gestation period of less than 37 weeks).  
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2 Abbreviations 
ACT  Alternating Cover Test 
AR  Autorefraction 
AS  Automated Screening 
CT  Cover Test 
CV  Colour Vision 
EI Eye Inspection 
EM  Eye Motility 
Fix  Fixation 
GDP  Gross Domestic Product 
GP General Practitioner 
Hir  Hirschberg test 
NICU Neonatal-intensive care unit 
PM Pursuit Movements 
PPP  Purchasing Power Parity 
PR  Pupillary Reflexes 
RE  Retinal Examination 
ROP Retinopathy of Prematurity 
RR  Red Reflex Testing 
SV  Stereopsis 
VA  Visual Acuity  
WHO  World Health Organisation 
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3 Population and Healthcare Overview 
The population of the Czech Republic is 10,591,323 (World Bank, 2018a) and birth rate is 
estimated at 10.7 births/1,000 population in 2016 (World Bank, 2018b).The change in 
population and birth rate from 1960 to 2017 is shown in Figure 1, graphs A and B 
respectively. 
The Czech Republic has a reported population density of 137 people per square kilometre in 
2017 and this has risen from 124 people per square kilometre in 1961 (World Bank, 2018c). 
In terms of healthcare facilities, the total density of hospitals in 2013 was 1.29 per 100,000 
population (WHO, 2016a). Infant mortality in 2017 is estimated at 2.6 deaths/1,000 live 
births in total (World Bank, 2018d). 
The average life expectancy in the Czech Republic is estimated at 78.3 years (World Bank, 
2018e), with a death rate of 10.2 deaths/1,000 population in 2016 (World Bank, 2018f). The 
Czech Republic has a gross national income per capita (PPP int. $, 2013) of $25,000 (WHO, 
2016b). The estimated total expenditure on health per capita in 2014 was $2,146 (Intl $) and 
the total expenditure on health in 2014 as percentage of GDP was 7.4% (WHO, 2016b). 
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Figure 1: Change in the Total Population and Birth Rate in the Czech Republic between 1960 and 2017 
 
Source: Information sourced from World Bank (2018) 
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4 Vision Screening Commissioning and Guidance 
In the Czech Republic, vision screening is organised nationally with no differences between 
regions. Vision screening is funded by compulsory national health insurance which is 
embedded into a general preventative child healthcare screening system. The content of the 
vision screening programme is decided upon by the Ministry of Health and screening vision 
began several decades ago. In 2005, congenital cataract screening for newborns was 
introduced. There is no protocol for the timing of review of the programme, however when 
required, any changes are decided upon by the Ministry of Health and funded by the 
government.  
Nurses have been identified as general professionals that do not currently screen in the Czech 
Republic but could do so with additional training. There is however currently no specific 
training to perform vision screening, it relies upon training during general study for paediatric 
general practitioners (GP).  
There are no methods for quality monitoring of vision screening imposed by the government, 
and there has been only degree level research investigating the vision screening programme. 
There have been no cost-effectiveness or clinical-effectiveness studies of the vision screening 
programme. 
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5 Screening programme  
The target conditions screened for by vision screening are congenital cataract and reduced 
visual acuity. There is no protocol for vision screening available. The health care professionals 
delivering vision screening, venue for screening and tests used vary depending on the age of 
the child. Specific details of the screening offered within each age group are described more 
fully in sections 5.1 to 5.4 below. 
5.1 Vision screening - Preterm babies 
Preterm babies are screened by either a paediatrician or an ophthalmologist in a hospital. A 
retinal examination is performed from 31st to 33rd gestational week or 4th-6th postnatal 
week, whichever term comes earlier. Subsequently, babies are screened at 2-week intervals, 
if there are signs of retinopathy of prematurity (ROP) the interval is shorter (1 week). If there 
are no signs of ROP, screening for ROP finishes at the age of 36th gestational week. The tests 
conducted at this age include eye inspection, fixation, red reflex testing, eye motility and 
retinal examination (ophthalmologist only). Referral is necessary if there is evidence of ROP, 
ƐƚƌĂďŝƐŵƵƐ ?ůŽƐƐŽĨĨŝǆĂƚŝŽŶ ?ŽƚŚĞƌĐŽŶŐĞŶŝƚĂůŽĐƵůĂƌĂďŶŽƌŵĂůŝƚǇŽƌĂƚƚŚĞƉĂƌĞŶƚƐ ?ƌĞƋƵĞƐƚ ? 
5.2 Vision screening - Birth to 3 months 
Well, healthy babies up to the age of 3 months are screened four times by a paediatrician or 
a nurse in either a hospital or a private clinic. The tests conducted at this age include eye 
inspection, fixation, red reflex testing and eye motility. Newborns are tested with eye 
inspection and red reflex at 2 days after release from hospital and with eye inspection, fixation 
and eye motility at 2 weeks, 6 weeks and 3 months. If a red reflex is not visible, babies are 
referred to an ophthalmologist. 
For other tests, no guidelines are available with regards to referral criteria, therefore, it is at 
the discretion of the examiner. There are no guidelines concerning the number of inconclusive 
tests that necessitate referral for further diagnostic examination, this also is at the discretion 
of the examiner.  
5.3 Vision screening - 3 months to 36 months 
ŚŝůĚƌĞŶĂŐĞĚ ?ƚŽ ? ?ŵŽŶƚŚƐĂƌĞƐĐƌĞĞŶĞĚďǇĂƉĂĞĚŝĂƚƌŝĐŝĂŶŽƌŶƵƌƐĞĂƚƚŚĞƉĂĞĚŝĂƚƌŝĐŝĂŶ ?Ɛ
office. The tests conducted in this age group include eye inspection, fixation and eye motility. 
Automated screening with PlusOptix is sometimes available, but not obligatory. Eye 
inspection and motility are checked at the age of 4-5 months, 6 months, 8 months, 10-11 
months, 12 months, and 18 months. Fixation is checked at the age of 4-5 months, 8 months, 
12 months, and 18 months. There are no guidelines on how many abnormal or inconclusive 
screening results necessitate referral for further diagnostic examination, this is at the 
ĞǆĂŵŝŶĞƌ ?ƐĚŝƐĐƌĞƚŝŽŶ ?
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5.4 Vision screening - 36 months to 7 years 
Children aged 36 months up to 7 years are screened by a paediatrician or a nurse at the office 
of the paediatrician. The tests conducted at this age include eye inspection, eye motility, 
visual acuity (VA) measurement, colour vision (Broschmann Dieter, Kuchenbecker Jörn) and 
automated screening (PlusOptix). Eye inspection, eye motility and VA are tested at the age of 
5 and 7 years, knowledge of colours is tested at the age of 5 years, colour vision is tested at 
the age of 7 years. VA is measured for the first time at 3 years of age. It is measured a second 
time at 5 years of age and then again at the ages of 7, 11, 13, 15, 17 and 19 years. The optotype 
charts used include Lea Symbols, HOTV and Tumbling E (Pflüger). There is no standardisation 
concerning whether these charts are logMAR, linear crowded tests or uncrowded. However, 
typically a linear crowded, with a testing range from 0.1  ? 1.0 (decimal) is used. The examiner 
decides which test to use and therefore there is no categorical difference between which 
chart is used at which age. There are no specific guidelines concerning the referral criteria, 
however in general:  
 
Ɣ Worse than 0.5 decimal (0.3 logMAR, 6/12 Snellen) at 3 years  
Ɣ Worse than 0.63 decimal) (0.2 logMAR, 6/9.5 Snellen) at 5 years  
Ɣ Worse than 0.8 decimal (0.1 logMAR, 6/7.5 Snellen) at 7 years and older ( 
Ɣ Difference between eyes or signs of strabismus at any age 
 
 
There are no guidelines on how many abnormal or inconclusive screening results necessitate 
referral for further diagnostic examination, this is at ƚŚĞĞǆĂŵŝŶĞƌ ?ƐĚŝƐĐƌĞƚŝŽŶ ? 
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Table 1: Healthcare professionals who conduct vision screening in each age group  
Table 1 Paediatrician Ophthalmologist Nurse 
Preterm babies  
 
9 
 
9 
× 
0 to 3 months  
 
9 
× 
 
9 
3 to 36 months  
 
9 
× 
 
9 
3 to 7 years  
 
9 
× 
 
9 
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Table 2: Vision screening tests used in vision screening for each age group  
Table 2 
Eye 
inspection 
Red reflex 
testing 
Fixation Eye motility Retinal 
examination 
Visual acuity  Colour 
Vision 
Automated 
screening 
Preterm babies  
 
9 
 
 
9 
 
 
9 
 
 
9 
 
 
9 
 
× × × 
0 to 3 months  
 
9 
 
 
9 
 
 
9 
 
 
9 
 
× × × × 
3 to 36 months  
 
9 
 
× 
 
9 
 
 
9 
 
× × × 
 
9 
 
3 to 7 years  
 
9 
 
× × 
 
9 
 
× 
 
9 
 
 
9 
 
 
9 
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Table 3: Location of vision screening for each age group  
Table 3 Hospital Paediatrician office Private Clinic 
Preterm babies  9 × × 
0 to 3 months  9 × 9 
3 to 36 months  × 9 × 
3 to 7 years  × 9 × 
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6 Automated Screening 
Automated vision screening is achieved using handheld, portable devices designed to detect 
presence of refractive error from 6 months of age. It provides objective results and is used to 
detect amblyopic risk factors. This differs from other methods used to screen children for 
amblyopia which focus on detection of the actual condition and the resulting visual loss.  
In the Czech Republic, PlusOptix is used. Paediatricians and ophthalmologists can hire the 
machines for approximately 3300 Czech Crowns (128.14 Euros*) per year. The paediatrician 
or ophthalmologist can buy the device for 8,400 Czech Crowns (326.21 Euros*). There are 
about 130 PlusOptix devices provided in the Czech Republic. The exact number of children 
screened using this device is not known, but it is estimated at 26,000 children per year. 
Paediatricians usually perform this in children at 6 months, 1.5 years and 3 years of age ? 
however, there are also private screening programmes in kindergartens, where the age of 
tested children is between 5-6 years. It is stand-alone test, however depending on the 
location of screening, it can be conducted in collaboration with other tests; for example, 
paediatricians also perform VA tests, ophthalmologists can measure refraction with objective 
methods. It is usually offered to all children. 
Referral criteria are as follows: 
Age 
(months) 
Anisometropia 
(Dioptres) 
Astigmatism 
(Dioptres) 
Myopia 
(Dioptres) 
Hyperopia 
(Dioptres) 
Anisocoria 
(mm) 
6-12 2.00 2.50 2.00 4.00 1.50 
12-36 1.50 1.50 2.00 3.00 1.50 
36-72 1.50 1.00 1.00 2.50 1.50 
72-240 1.00 1.00 1.00 2.00 1.50 
 
Referral in children who pass the VA test but fail on PlusOptix is at the discretion of the 
examiner. If a paediatrician conducts the testing, children are usually referred to 
ophthalmologist if they fail the PlusOptix and pass the VA test. There is no comparative data 
between regions who do use and do not use PlusOptix, or on the outcomes of screening by 
visual acuity/PlusOptix because there are no areas of the Czech Republic that do not use 
PlusOptix.  
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7 Provision for Visually Impaired  
In the Czech Republic, there are 9 state schools (650 children attend) and 7 grammar schools 
(400 children attend) for blind or severely visually impaired children. However, many children 
are integrated into regular mainstream schools with the help of personal assistants. The costs 
per child for these schools is not known. There is special support for visually impaired children 
who attend regular primary school; the ophthalmologist can prescribe special tools, including:  
x Magnifying newspapers, books and websites on computers 
x Technology that magnifies documents using phone and tablet software (Enlarge on 
the Go) 
x Technology that reads documents and books for the individual 
x Braille 
x Methods of simplifying computer work 
x Talking phones 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
*Currency conversion as of 28/12/2018 
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8 Knowledge of existing screening programme 
8.1 Prevalence/Diagnosis  
The prevalence of treated or untreated amblyopia at the age of 7 years is estimated at 2.5%, 
and the prevalence of persistent amblyopia at the age of 7 years is estimated at 2% 
(Varadyová, 2007), but there is no accurate statistical data available for these measures. In 
2015, the prevalence of strabismus was detailed by the Institute of Health Information and 
Statistic of the Czech ZĞƉƵďůŝĐĂƐ ? ? ? ? ? ? ? ? ? ? ?ƉĞŽƉůĞ ? ?KĨƚĂůŵŽůŽŐŝĞ ?j/^Z ? ? ? ? ? ?) i.e. 
0.77%. However, the classification of type of strabismus is not available and the reporting 
physicians only report the presence of diagnosis of strabismus, there is no information 
provided about age. There is no further data available.  
8.2 Coverage 
It is estimated that 100% of children are invited for vision screening, this is conducted by the 
general practitioner (GP) through different sources including letters. The coverage and 
attendance of all vision screening, including visual acuity measurements is estimated at 
almost 100%.  
8.3 Screening evaluation 
The percentage of false negative and false positive results is not available. The positive 
predictive value, sensitivity and specificity of vision screening are also not available.  
8.4 Treatment success 
Following screening referral before the age of 7 years, the percentage of children treated for 
strabismus is not known. There is no further data available. The percentage of compliance 
with referral, after an abnormal screening test result is estimated at 90%. However, these is 
no registration or documentation of noncompliance with referral after an abnormal screening 
test result. It is not known how many patients are treated for congenital cataract, amblyopia 
and strabismus each year. 
Ophthalmologists are the only professionals that prescribe glasses for children under the age 
of 7 years. Other treatment options include patching, cataract surgery, strabismus surgery, 
ptosis surgery, glaucoma surgery and retinoblastoma treatment. All eligible children are 
offered treatment.  
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9 Costs of vision screening in children 
9.1 Cost of vision screening  
The salary costs (range) per year for vision screening professional is not available. The salary 
costs (range) per hour for vision screening professionals is estimated at 10-20 Euros. It is 
estimated that it costs approximately 20,000 Euros to train vision screening professionals 
between leaving secondary education and qualification. The total screening costs per year for 
vision screening is not available. Screening of visual functions is part of general follow-ups. 
9.2 Cost of treatment for amblyopia 
The estimated costs for treatment of typical patients with refractive and strabismic 
amblyopia, including follow-up are:  
Ɣ Visit to ophthalmologist: 20 Euros 
Ɣ Visit to orthoptist: long visit 13 Euro, short visit 6 Euros 
Ɣ 1 session of active stimulation (consists of CAM vision stimulation, troposcope and 
stereoscope training, cheiroscope training and specialised computer programme for 
details recognition): 10 Euros 
Ɣ Patches: 15 Euros/3 months 
Ɣ Glasses: 40 Euros - amount that can be claimed for from insurance.  
Ɣ Extra money possible only for glasses and patches.  
Ɣ Number of visits depends on age and disease type, usually per year = ophthalmologist 
twice, long orthoptic visit twice, 20 sessions of stimulation, glasses = 306 Euros per 
year.  
9.3 Cost of Treatment for strabismus  
The estimated costs for strabismus surgery including follow up are:  
Ɣ Surgery: 100 Euros 
Ɣ Visit to orthoptist: long visit 13 Euros, short visit 6 Euros (once or twice a year) 
Ɣ Visit to ophthalmologist: 20 Euros (at the beginning usually in 1 week, 3 months, 6 
months) 
Ɣ 1 session of active stimulation: 10 Euros (max 20 lectures a year) 
Ɣ Patches: 15 Euros/3 months 
Ɣ Glasses: 40 Euros 
9.4 Cost of treatment for cataract 
The estimated costs for congenital cataract surgery including follow up of deprivation 
amblyopia are:  
Ɣ Surgery: 550 Euros 
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Ɣ Check-up under general anaesthetic (at the beginning every 3 months, then every 6 
months until 3-4 years): 100 Euros 
Ɣ Visit to orthoptist: long visit 13 Euros, short visit 6 Euros (once or twice a year) 
Ɣ Visit to ophthalmologist: 20 Euros (at the beginning every 2-3 weeks, then every 2-3 
months, then every 6 months and once a year in preschool age) 
Ɣ 1 session of active stimulation: 10 Euros (max 20 lectures a year) 
Ɣ Patches: 15 Euros/3 months 
Ɣ Glasses: 40 Euros  
Summary Vision Screening Data: Czech Republic                                                                            
 
14 
 
10 References 
Bergerová, D., & Jandová, R. (2018). Prevention of eye defects in children in Kindergartens. 
ZĞƚƌŝĞǀĞĚ ĨƌŽŵ
ŚƚƚƉƐ P ? ?ǁǁǁ ?ƉĨ ?ũĐƵ ?Đǌ ?ĞĚƵĐĂƚŝŽŶ ?ĚĞƉĂƌƚŵĞŶƚ ?Đǌǀ ?ĂƌĐŚŝǀ ?ǌƉ ?ŵƐ ? ? ? ? ? ?WƌĞǀĞŶĐĞ ?ŽĐŶŝĐŚ ?ǀĂĚ
 ?Ƶ ?ĚĞƚŝ ?ǀ ?D^ ?ƉĚĨ 
KĨƚĂůŵŽůŽŐŝĞ  ? j/^ Z ?  ? ? ? ? ? ) ? ZĞƚƌŝĞǀĞĚfrom https://www.uzis.cz/category/tematicke-
rady/zdravotnicka-statistika/oftalmologie [Accessed 18 December 2018]. 
The World Bank (2018a). Population, total | Data. [online] Available at: 
https://data.worldbank.org/indicator/SP.POP.TOTL?locations=CZ [Accessed 18 December 
2018]. 
The World Bank. (2018b). Birth rate, crude (per 1,000 people) | Data. [online] Available at: 
https://data.worldbank.org/indicator/SP.DYN.CBRT.IN?locations=CZ [Accessed 18 December 
2018]. 
The World Bank. (2018c). Population density (people per sq. km of land area) | Data. [online] 
Available at: https://data.worldbank.org/indicator/EN.POP.DNST?locations=CZ [Accessed 18 
December 2018]. 
The World Bank. (2018d). Mortality rate, infant (per 1,000 live births) | Data. [online] 
Available at: https://data.worldbank.org/indicator/SP.DYN.IMRT.IN?locations=CZ [Accessed 
18 December 2018]. 
The World Bank. (2018e). Life expectancy at birth, total (years) | Data. [online] Available at: 
https://data.worldbank.org/indicator/SP.DYN.LE00.IN?locations=CZ [Accessed 18 December 
2018]. 
The World Bank. (2018f). Death rate, crude (per 1,000 people) | Data. [online] Available at: 
https://data.worldbank.org/indicator/SP.DYN.CDRT.IN?locations=CZ [Accessed 18 December 
2018]. 
Varadyová B. (2007). Optimization of active screening of amblyogenic refractive defects in 
children and determination of the most appropriate method of comprehensive treatment of 
amblyopia (Ph.D. dissertation). Grada Publishing, 7 s, 711-13 s , ISBN 978 ʹ 80 ʹ 247 ʹ 1163 ʹ 
8. [Accessed 18 December 2018]. 
World Health Organisation (WHO). 2016a. Health Infrastructure - Data by country. [ONLINE] 
Available at: http://apps.who.int/gho/data/view.main.30000. [Accessed 18 December 2018]. 
World Health Organisation (WHO). 2016b. Countries, Czechia. [ONLINE] Available at: 
http://www.who.int/countries/cze/en/. [Accessed 18 December 2018]. 
 
 
